In many children with short stature, the etiology of the decreased linear growth remains unknown. We sought to identify the underlying genetic etiology in a patient with short stature, irregular growth plates of the proximal phalanges, developmental delay, and mildly dysmorphic facial features. Exome sequencing identified a de novo, heterozygous, nonsense mutation (c.1606C>T:p.R536X) in QRICH1. In vitro studies confirmed that the mutation impaired expression of the QRICH1 protein. SiRNA‐mediated knockdown of Qrich1 in primary mouse epiphyseal chondrocytes caused downregulation of gene expression associated with hypertrophic differentiation. We then identified an unrelated individual with another heterozygous de novo nonsense mutation in QRICH1 who had a similar phenotype. A recently published study identified QRICH1 mutations in three patients with developmental delay, one of whom had short stature. Our findings indicate that QRICH1 mutations cause not only developmental delay but also a chondrodysplasia characterized by diminished linear growth and abnormal growth plate morphology due to impaired growth plate chondrocyte hypertrophic differentiation.
[1]
A. Brady,et al.
Phenotypic spectrum associated with de novo mutations in QRICH1 gene
,
2018,
Clinical genetics.
[2]
T. Markello,et al.
BRF1 mutations in a family with growth failure, markedly delayed bone age, and central nervous system anomalies
,
2017,
Clinical genetics.
[3]
M. Phillip,et al.
Short and tall stature: a new paradigm emerges
,
2015,
Nature Reviews Endocrinology.
[4]
L. Biesecker.
The new world of clinical genomics.
,
2012,
The Journal of clinical endocrinology and metabolism.
[5]
Manuel Corpas,et al.
DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources.
,
2009,
American journal of human genetics.